用新带治疗便失禁的人造:IDEAL 2b未来多中心试验
Christopher Dawoud1, José Manuel Devesa2, Mathias Löhnert3
1Department of General Surgery, Medical University of Vienna, Vienna, Austria.
BJS open
|October 22, 2025
概括
一种新型的人工肠 (SimplyFI带) 在改善便失禁 (FI) 症状方面显示出短期的安全性和有效性. 需要进一步的研究来证实这种新的FI治疗的长期益处.
科学领域:
- 胃肠病学 胃肠病学
- 手术创新 在外科创新.
- 医疗器械技术 医疗器械技术
背景情况:
- 便失禁 (FI) 管理面临重大挑战,需要新的治疗选择.
- 对于许多患有FI的患者来说,保守的治疗方法往往不足.
- 开发创新的设备来改善关节的功能至关重要.
研究的目的:
- 评估SimplyFI带的安全性和有效性,这是一个人工肠,用于治疗便失禁.
- 评估SimplyFI植入后FI患者的功能改善和生活质量变化.
- 为了记录与SimplyFI设备相关的手术内和术后并发症.
主要方法:
- 一个探索性的前性多中心研究,遵循IDEAL 2b框架.
- 包括耐保守治疗的FI耐药患者.
- 使用圣马克失禁分数 (SMIS) 和便失禁生活质量量量表 (FIQLS) 评估功能性结果,并进行肠测量.
主要成果:
- 招募了18名患者 (17名女性,1名男性),中位数手术时间为27分钟,中位数住院时间为2天.
- 发生了一次手术后并发症;一名患者 (5.6%) 由于不适而需要切除带.
- 植入后12个月观察到SMIS和FIQLS得分的显著改善 (分别为P = 0.013和P = 0.006).
- 门测量显示3个月后门静止压力显著增加 (P = 0.037),但在12个月后这种情况没有持续.
结论:
- 简单FI带证明了便失禁患者的短期安全性和功能改善.
- 该设备为具有挑战性的FI病例提供了潜在的新治疗方式.
- 需要进行更长的后续研究,以充分确定SimplyFI带的长期疗效和作用.
相关概念视频
01:21Inflammatory Bowel Disease V: Surgical Management
441
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
441
01:21Drugs for Treatment of Constipation-Predominant IBS
712
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
712